Within Hours, Surgical Implant Lets Paralyzed Patients Walk

Multiple clinical trial participants who have severe spinal injuries were able to stand, walk, and perform specific activities after just one day of using an implant surgically embedded in their spines.

Written byDan Robitzski
| 2 min read
Left: Two men wearing coats and hats who are standing side-by-side on a sidewalk walk towards the camera with the assistance of walkers. Right: artist’s rendering of an oval-shaped medical implant dotted with electrodes that has wires protruding from one end.
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

When Michel Rocatti completely severed his spinal cord in a 2017 motorcycle accident, he permanently lost all sensation in and control over his legs. For years, Rocatti was unable to walk—until an experimental implant was surgically embedded into his spine, re-completing the broken biological circuit between his spinal cord and the severed nerves, The Guardian reports.

When prompted, the device sends activity-specific pulses of electricity to various nerves that were cut off from the central nervous system, allowing the Rocatti and other paralyzed people to send the appropriate stimulation and instructions to their legs. Rocatti and the other two participants in an ongoing clinical trial were able to stand, walk, use bicycle pedals, and kick their legs in a swimming pool within hours of having the flexible, multi-electrode device embedded into their spines, according to research published Monday (February 7) in Nature Medicine. The device and software, developed by researchers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

  • black and white image of young man in sunglasses with trees in background

    Dan is an award-winning journalist based in Los Angeles who joined The Scientist as a reporter and editor in 2021. Ironically, Dan’s undergraduate degree and brief career in neuroscience inspired him to write about research rather than conduct it, culminating in him earning a master’s degree in science journalism from New York University in 2017. In 2018, an Undark feature Dan and colleagues began at NYU on a questionable drug approval decision at the FDA won first place in the student category of the Association of Health Care Journalists' Awards for Excellence in Health Care Journalism. Now, Dan writes and edits stories on all aspects of the life sciences for the online news desk, and he oversees the “The Literature” and “Modus Operandi” sections of the monthly TS Digest and quarterly print magazine. Read more of his work at danrobitzski.com.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo